Home arrow Gastroenterology
Advertisement

Main Menu

Home
Advertisement
Advertisement

Most popular articles


Practical Management Of Norovirus Outbreaks - A New One-Day Course From The Royal Institute Of Publi
Wednesday, 09 January 2008
Noroviruses are a group of viruses that are the most general cause of acute gastroenteritis and the HPA estimates that they affect between 600,000 and a million people in the UK each year.

FDA Approves Rotarix [Rotavirus Vaccine, Live, Oral], The First Vaccine Licensed To Complete The Rot
Sunday, 06 April 2008
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants.

Ethicon Endo-Surgery Submits Application To FDA For Approval Of The Sedasys? System The First Comput
Monday, 31 March 2008
Ethicon Endo-Surgery announced that the company has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the SEDASYS™ System, the first computer-assisted personalized sedation (CAPS) system.

New Procedure In Diagnosing Small Bowel Disorders Proves Efficient And Effective
Saturday, 12 April 2008
Sonoenteroclysis, a new sonographic way in evaluating and diagnosing little bowel disorders is an effective alternative to the common way of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India.

Increased Hepcidin Expression: A Novel Oncogenic Signalling Mechanism
Wednesday, 19 March 2008
Historically anaemia, which is associated with colorectal cancer, has been attributed to blood loss. Previous studies have elegantly shown that the anti-microbial peptide hepcidin can also induce anaemia as a consequence of infection and or inflammation.

Over 100 Cases Of Salmonella Linked To Pet Turtles In The US
Monday, 28 January 2008
The US Centers for Disease Control and Prevention said last week it is still investigating a 9 month multistate outbreak of gastroenteritis that has infected over 100 people who most likely caught Salmonella from little pet turtles.

For Crohn's Patients, Omega-3 Fatty Acids Not Effective In Preventing Relapse
Tuesday, 08 April 2008
Administration of omega-3 fatty acid supplements did not appear to advance the rate of relapse in patients with Crohn's disease, according to a study released on April 9, 2008 in JAMA.
Advertisement
Gastroenterology
New Procedure In Diagnosing Small Bowel Disorders Proves Efficient And Effective Print E-mail
User Rating: / 0
Saturday, 12 April 2008
Sonoenteroclysis, a new sonographic way in evaluating and diagnosing little bowel disorders is an effective alternative to the common way of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India.
Read more...
 
Napo Announces Successful Clinical Results In Phase 2 Study Of Crofelemer In Acute Adult Infectious Print E-mail
User Rating: / 0
Friday, 11 April 2008
Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark).
Read more...
 
For Crohn's Patients, Omega-3 Fatty Acids Not Effective In Preventing Relapse Print E-mail
User Rating: / 0
Tuesday, 08 April 2008
Administration of omega-3 fatty acid supplements did not appear to advance the rate of relapse in patients with Crohn's disease, according to a study released on April 9, 2008 in JAMA.
Read more...
 
The GI Company To Present Phase I & II Oral Mucositis Data At MASCC / ISOO Annual Meeting Print E-mail
User Rating: / 0
Tuesday, 08 April 2008
The GI Company, Inc.
Read more...
 
Recombinant Human Intestinal Trefoil Factor (rhITF) Oral Spray For Prophylaxis Of Chemotherapy-induc Print E-mail
User Rating: / 0
Tuesday, 08 April 2008
The GI Company, Inc.
Read more...
 
FDA Approves ROTARIX(R) Rotavirus Vaccine Print E-mail
User Rating: / 0
Monday, 07 April 2008
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants.
Read more...
 
FDA Approves Rotarix [Rotavirus Vaccine, Live, Oral], The First Vaccine Licensed To Complete The Rot Print E-mail
User Rating: / 0
Sunday, 06 April 2008
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants.
Read more...
 
FDA Approves New Vaccine To Prevent Gastroenteritis Caused By Rotavirus Print E-mail
User Rating: / 0
Friday, 04 April 2008
The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children.
Read more...
 
SAGES/ACS Fundamentals Of Laparoscopic Surgery (FLS) Program Receives Landmark Grant From Covidien Print E-mail
User Rating: / 0
Friday, 04 April 2008
The Fundamentals of Laparoscopic Surgery (FLS), a joint educational program from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American College of Surgeons (ACS), has received a $1.
Read more...
 
Mayo Clinic Identifies Infection Risks For Patients With Inflammatory Bowel Disease Print E-mail
User Rating: / 0
Thursday, 03 April 2008
A new Mayo Clinic study finds that patients who are 50 or older and take multiple immunosuppressive medications for inflammatory bowel disease have a higher risk for developing infections. The study is published in this month's issue of Gastroenterology.
Read more...
 
Burden Of Gastroenteritis On The Island Of Ireland Estimated At Over 135 Million Euros Print E-mail
User Rating: / 0
Wednesday, 02 April 2008
1st April 2008: A new safefood study - The Economic Impact of Gastroenteritis on the Island of Ireland has revealed the total burden of gastroenteritis on the economy for the island of Ireland is estimated at over €135 million per annum.
Read more...
 
Fewer Food Poisoning Stomach Upsets With Prebiotics Print E-mail
User Rating: / 0
Wednesday, 02 April 2008
Natural sugars found in breast milk that are now included in prebiotic foods may help in the fight against Salmonella and other food poisoning bacteria, scientists heard today (Wednesday 2 April 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh...
Read more...
 
Researchers Examine A Possible Link Between Bacteria Found In The Human Digestive System And Obesity Print E-mail
User Rating: / 0
Wednesday, 02 April 2008
Obesity is more than a cosmetic concern since it increases a person's risk for developing high blood pressure, diabetes and many other serious health problems. It's well understood that consuming more calories than you expend through exercise and daily activities causes weight gain.
Read more...
 
Epistem To Provide Preclinical Efficacy Testing Services For Exponential Biotherapies Print E-mail
User Rating: / 0
Tuesday, 01 April 2008
Epistem (LSE: EHP) announced that Exponential Biotherapies, Inc. (EBI) of Virginia, USA, have contracted Epistem to provide their specialised preclinical efficacy testing services for agents likely to defend the gastrointestinal tract against radiation damage.
Read more...
 
Ethicon Endo-Surgery Submits Application To FDA For Approval Of The Sedasys? System The First Comput Print E-mail
User Rating: / 0
Monday, 31 March 2008
Ethicon Endo-Surgery announced that the company has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the SEDASYS™ System, the first computer-assisted personalized sedation (CAPS) system.
Read more...
 
Orexo Announces Results Confirming The Clinical Profile Of OX17 In Reflux Disease (GERD) Print E-mail
User Rating: / 0
Friday, 28 March 2008
New clinical data from a phase II study affirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. quick, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient.
Read more...
 
The GI Company To Present Phase II Oral Mucositis Data At ASCO Annual Meeting Print E-mail
User Rating: / 0
Thursday, 27 March 2008
The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, announced that an abstract detailing results from a Phase II clinical trial (2006 - ITF - 009) has been accepted for oral presentation at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Read more...
 
Repligen Initiates Phase 3 Clinical Trial Of RG1068 For Pancreatic MRI Imaging Print E-mail
User Rating: / 0
Thursday, 27 March 2008
Repligen Corporation (Nasdaq: RGEN) announced that the Company has initiated a Phase 3 clinical trial to evaluate the use of RG1068, synthetic human secretin, to enhance the assessment of pancreatic duct structures by magnetic resonance imaging (MRI).
Read more...
 
$6.5 Million Grant Awarded To UT Southwestern By NIH To Develop New Antibiotic Print E-mail
User Rating: / 0
Wednesday, 26 March 2008
Researchers at UT Southwestern Medical Center have been awarded a $6.5 million grant from the National Institute of Allergy and Infectious Diseases to develop a new anti-microbial compound to goal bacterial pathogens like Salmonella and Escherichia coli.
Read more...
 
Updated Treatment Guidelines For Barrett's Esophagus Offer New Recommendations For Challenging Clini Print E-mail
User Rating: / 0
Wednesday, 26 March 2008
Due to the rise in the incidence of esophageal cancers in the United States, and as a result of weighty scientific advances in the area of Barrett's esophagus, physician experts from the American College of Gastroenterology have released updated guidelines for the diagnosis, surveillance and...
Read more...
 
How HIV Turns Food-Poisoning Into Lethal Infection Print E-mail
User Rating: / 0
Tuesday, 25 March 2008
Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea. Now, UC Davis School of Medicine scientists have discovered how salmonella becomes lethal for AIDS patients.
Read more...
 
Following The Life Cycle Of Salmonella Enteritidis In The Internal Organs Print E-mail
User Rating: / 0
Thursday, 20 March 2008
The Incidence of Salmonella enteritidis infection is usual in hospitals for children and the old, and amongst immuno-suppressed individuals. Salmonella enteritidis can be transmitted to humans through the food production chain.
Read more...
 
Potential New Method Of Pancreaticojejunostomy Print E-mail
User Rating: / 0
Thursday, 20 March 2008
A soft pancreatic texture with a narrow pancreatic ductal size creates a high risk for the development of a pancreatic fistula after pancreaticoduodenectomy, frequently leading to death.
Read more...
 
What Effect Does Melatonin Have In Colitis? Print E-mail
User Rating: / 0
Thursday, 20 March 2008
In rats with experimental colitis, the marked increase in bacterial translocation in postcolitis rats has been reversed by melatonin administration. This is because of melatonin's anti-inflammatory and anti-apoptotic effects.
Read more...
 
DRC: Fewer New Cholera Patients In Katanga Province Print E-mail
User Rating: / 0
Thursday, 20 March 2008
Since December 2007, cholera outbreaks have affected thousands of people in the cities of Lubumbashi and Likasi in southern Katanga province, Democratic Republic of Congo. For the last 3 weeks, on the contrary, the number of new patients at MSF clinics in these areas have been decreasing.
Read more...
 
Do Bacterial Combinations Result In Enhanced Cytokine Production? No! Print E-mail
User Rating: / 0
Wednesday, 19 March 2008
Probiotic bacteria, defined as living microorganisms that have beneficial effects on human health, have been used for the prevention and treatment of a diverse range of disorders. However, the ways in which probiotic bacteria elicit their health effects are not completely understood.
Read more...
 
How Is H Pylori Adhesion To Gastric Cells Associated With MUC1 Mucin VNTR Size? Print E-mail
User Rating: / 0
Wednesday, 19 March 2008
The Gram negative bacterium H pylori is involved in the pathogenesis of several gastrointestinal diseases, ultimately leading to gastric carcinoma. Adhesion of the bacteria to the gastric mucosa is an valuable step for colonization and infection.
Read more...
 
Increased Hepcidin Expression: A Novel Oncogenic Signalling Mechanism Print E-mail
User Rating: / 0
Wednesday, 19 March 2008
Historically anaemia, which is associated with colorectal cancer, has been attributed to blood loss. Previous studies have elegantly shown that the anti-microbial peptide hepcidin can also induce anaemia as a consequence of infection and or inflammation.
Read more...
 
Treatment For Esophageal Perforation Print E-mail
User Rating: / 0
Wednesday, 19 March 2008
Management of ingested foreign bodies is a usual clinical meet. Complications of this pathology are dependent on a patient's age, the nature and localization of the foreign body, the presence of a perforation, and first management procedures.
Read more...
 
Predictive Genetic Test For Bowel Cancer Treatment Is Introduced In The UK Print E-mail
User Rating: / 0
Tuesday, 18 March 2008
Amgen Limited UK and Lab21 have announced their partnership to introduce a new genetic therapy test for enhanced bowel cancer treatment in the UK.
Read more...
 
<< Start < Prev 1 2 3 4 5 Next > End >>

Results 1 - 30 of 137
Latest news in this category:

New Procedure In Diagnosing Small Bowel Disorders Proves Efficient And Effective
Saturday, 12 April 2008
Sonoenteroclysis, a new sonographic way in evaluating and diagnosing little bowel disorders is an effective alternative to the common way of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India.

Napo Announces Successful Clinical Results In Phase 2 Study Of Crofelemer In Acute Adult Infectious
Friday, 11 April 2008
Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark).

For Crohn's Patients, Omega-3 Fatty Acids Not Effective In Preventing Relapse
Tuesday, 08 April 2008
Administration of omega-3 fatty acid supplements did not appear to advance the rate of relapse in patients with Crohn's disease, according to a study released on April 9, 2008 in JAMA.

FDA Approves ROTARIX(R) Rotavirus Vaccine
Monday, 07 April 2008
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants.

FDA Approves Rotarix [Rotavirus Vaccine, Live, Oral], The First Vaccine Licensed To Complete The Rot
Sunday, 06 April 2008
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants.